pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

EMD SERONO

USupdated 1mo ago
Website ↗
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view EMD SERONO jobs →

News

  • J&J again cuts New Jersey workforce, letting 87 go
    Follow along as BioSpace tracks job cuts and restructuring initiatives.
    biospace · 2h ago
  • Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label
    Plus news about Tevard Biosciences, InduPro, EMD Serono, Shionogi, Bayer's Hyrnuo. Disc's competitor for Takeda's blood disorder drug Mimrylo: Disc Medicine shared initial data from its Phase 2 RES…
    endpoints · 11d ago
  • Out of sight, out of work? What’s driving remote job cuts
    Biopharma professionals sometimes find themselves out of jobs when employers want to bring staff back into the office, as recently seen at biotech EMD Serono and Exelixis.
    biospace · 1mo ago
  • Merck KGaA lays off 20 staffers in latest blow to US research team
    The Massachusetts research site for Merck KGaA’s North American division, EMD Serono, has decided to hand pink slips to 20 staffers, Fierce has learned.
    fiercebiotech · 1mo ago
  • July's biopharma layoffs affect 466 employees, a 94% year-over-year drop
    Last month, biopharmas cutting or planning to cut their workforces included Amgen, GSK and Novartis, with Novartis’ layoffs affecting the most people.
    biospace · 1mo ago
  • Fierce Biotech Layoff Tracker 2026: Sionna halves staff; Merck trims more NJ jobs
    As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
    fiercebiotech · 9mo ago
identifiers
country
US
source
openfda_drugsfda
mentioned in
6news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?